Bio-Rad Expands Molecular Portfolio
with Synthetic Negative and HAI
Negative Run Controls
Bio-Rad Laboratories has expanded its molecular offering of quality controls with the launch of two new Exact Diagnostics products: Synthetic Negative Run Control, which complements the Tick-borne, Meningitis/Encephalitis and Sexually-Transmitted Infections products; and HAI Negative Run Control, which complements the Hospital-Associated Infections products.
READ MORE »
READ MORE »
Bio-Rad Launches Molecular Blood
Screening Controls in Europe
Bio-Rad Laboratories has announced that Exact Diagnostics HBV, HCV and HIV-1 Screen Controls are now available to laboratories in Europe. These controls are designed to monitor the performance of blood donor screening assays.
READ MORE »
READ MORE »
Bio-Rad Launches Molecular Virology Controls in Europe
|
Bio-Rad Laboratories announces the launch of its Exact Diagnostics HBV, HCV and HIV-1 Run Controls to laboratories in Europe.
READ MORE » |
Bio-Rad Launches SARS-CoV-2 S Gene Variant Controls for Research Testing
|
The Exact Diagnostics SARS-CoV-2 S Gene Alpha, Beta, Epsilon, Gamma and Delta-Kappa Variants Controls are intended to be validated as independent external run controls and used for research testing with molecular assays targeting mutations in the Spike (S) gene of SARS-CoV-2 variants to monitor assay performance.
|
Bio-Rad Launches SARS-CoV-2, Flu, RSV Run Controls for Multiplexed Respiratory PCR Assays |
|
To enable laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular respiratory assays and to test for operator proficiency, Bio-Rad launches the SARS-CoV-2, Flu, RSV Positive and Negative Run Controls. The product contains whole organism SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus (A), with a human genomic DNA background.
READ MORE » |
Bio-Rad Launches Exact Diagnostics Transplant Quality Control Product Line in European Market
|
Bio-Rad Laboratories announces the launch of its Exact Diagnostics transplant product line consisting of molecular standards and quality controls to laboratories in Europe.
READ MORE » |
Exact Diagnostics Announces the Launch of the SARS CoV-2 Standard for COVID-19 Coronavirus Research Testing
|
To support COVID-19 assay validation, Exact Diagnostics launches the SARS CoV-2 Standard and Negative for research use. The products contain RNA transcript and genomic DNA allowing laboratories to validate testing of the entire process of a molecular assay including extraction, amplification, and detection.
|
|
SARS-CoV-2 Standard
The EDX SARS-CoV-2 Standard is manufactured with synthetic RNA transcripts containing five gene targets
(E, N, ORF1ab, RdRP and S Genes of SARS-CoV-2). |
SARS-CoV-2 Negative
The EDX SARS-CoV-2 Negative contains 75,000 cp/ml of human gDNA
|
Exact Diagnostics Joins Bio-Rad Laboratories
|
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, welcomes molecular diagnostic control manufacturer Exact Diagnostics.
READ MORE » |
Announcing EDX Respiratory
Positive & Negative Run Controls
|
The EDX RP Positive Run Control contains 22 respiratory analytes. This multiplex control is a combination of whole, intact virus and bacteria, that have been heat or chemically inactivated, and synthetic RNA transcripts. The multiplex control is intended to test the entire process of a molecular assay including extraction, detection, and amplification. EDX RP Positive Run Control is internally value assigned using digital droplet PCR. EDX RP Positive Run Control is formulated in synthetic matrix which contains preservatives.
|
The Respiratory Negative Run Control is a negative control. These controls are intended to test the entire process of a variety of molecular assays from extraction, detection, and amplification. The Respiratory Negative Run Controls are formulated in Stabilizing Matrix.
|
Announcing EDX Tick Borne Run Controls
The EDX Tick Borne Run Controls are intact whole organism that has been
heat inactivated.The control is intended to test the entire process of a variety
of molecular assays from extraction, detection, and amplification.
heat inactivated.The control is intended to test the entire process of a variety
of molecular assays from extraction, detection, and amplification.
Exact Diagnostics Tick Borne Run Controls are value assigned using digital droplet PCR.
View the complete list of
Exact Diagnostics catalog products.
Exact Diagnostics catalog products.
 cGMP manufactured materials,
nimble turnaround time, customized to your needs. |
 Sign up to receive the latest
news about Exact Diagnostics product developments. |
Find out how
|
|
